A leading Japanese pharmaceutical firm specializing in research, development, and commercialization of innovative drugs, particularly in oncology and rare diseases. Investors monitor its pipeline and partnerships with global pharma giants like Roche.
6 members of Congress have disclosed 19 trades in Chugai Pharmaceutical Co., Ltd. (CHGCY), a Healthcare company. The buy/sell breakdown shows 9 purchases versus 10 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-04-09 | Josh Gottheimer | sell | $1K – $15K |
| 2024-06-21 | Josh Gottheimer | sell | $1K – $15K |
| 2024-04-04 | Josh Gottheimer | sell | $1K – $15K |
| 2023-08-18 | Josh Gottheimer | buy | $1K – $15K |
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2023-03-31 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $1K – $15K |
| 2021-02-17 | Peter Meijer | sell | $15K – $50K |
| 2020-04-14 | Greg Gianforte | sell | $50K – $100K |
| 2020-04-13 | Josh Gottheimer | sell | $1K – $15K |
| 2020-01-13 | Greg Gianforte | buy | $15K – $50K |
| 2019-06-24 | Donna Shalala | sell | $1K – $15K |
| 2019-03-01 | Greg Gianforte | buy | $100K – $250K |
| 2019-02-21 | Donna Shalala | buy | $1K – $15K |
| 2019-02-20 | Donna Shalala | buy | $1K – $15K |
| 2019-02-20 | Josh Gottheimer | buy | $1K – $15K |
| 2019-02-19 | Donna Shalala | buy | $1K – $15K |
| 2019-02-19 | Josh Gottheimer | buy | $1K – $15K |
| 2018-12-17 | JAMES B. RENACCI | sell | $50K – $100K |